Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination (2017)
Attributed to:
Centre for Cognitive Ageing & Cognitive Epidemiology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/1747493017731947
PubMed Identifier: 28906205
Publication URI: http://europepmc.org/abstract/MED/28906205
Type: Journal Article/Review
Parent Publication: International Journal of Stroke
Issue: 5
ISSN: 1747-4930